Physician profile
Jacquelyn Glenn
NPI 1831272822
$20,368.11
in general payments reported to CMS, 2019-2025
28 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $11K · 2021: $257 · 2022: $7,353 · 2023: $806 · 2024: $468 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,800 · Travel and Lodging: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.78 |
| Travel and Lodging | $146.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,699.60 | 2020-2022 | |
| Kerecis Limited | $1,038.61 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $388.59 | 2021-2025 | Nuzyra |
| Davol INC. | $388.05 | 2023 | Phasix Mesh |
| Vaporox, INC. | $332.01 | 2024-2025 | |
| Biowound Solutions, INC. | $301.75 | 2025 | Bio-Connekt |
| Kci USA, INC. | $200.19 | 2019-2023 | Activ.A.C., V.A.C. Dermatac |
| Integra Lifesciences Corporation | $190.89 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $137.28 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $103.53 | 2021-2025 | Pico, Collagenase Santyl, Renasys Touch |
| Urgo Medical North America, LLC | $71.04 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Organogenesis INC. | $62.05 | 2021-2022 | |
| Dilon Technologies, INC. | $61.83 | 2024 | Hemoblast Bellows |
| Imbed Biosciences INC. | $58.58 | 2023 | |
| Aroa Biosurgery Incorporated | $45.37 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reddress USA, INC. | $42.00 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $30.08 | 2021-2022 | |
| Hartmann USA, INC. | $24.12 | 2023 | Two Press |
| Cumberland Pharmaceuticals, INC. | $24.01 | 2024 | Vibativ |
| Solventum Corporation | $22.54 | 2025 | Activ.A.C., 3m Cavilon, V.A.C. Dermatac |
| Ossur Americas, INC. | $21.93 | 2024 | |
| Ovik Health, LLC | $20.98 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.27 | 2020 | |
| Acell, INC. | $20.15 | 2020 | |
| Medline Industries LP | $17.59 | 2019 | |
| Baxter Healthcare | $16.97 | 2025 | |
| Convatec INC. | $15.10 | 2022 | |
| Celularity INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Glenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.